Immatics (IMTX) Other Non-Current Assets (2019 - 2025)
Immatics' (IMTX) quarterly Other Non-Current Assets came in at $2.2 million in Q4 2025, up 61.22% year-on-year from $1.3 million in Q4 2024, and up 124.64% quarter-over-quarter from $958625.2 in Q3 2025.
Immatics (IMTX) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Immatics has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $2.2 million for Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $2.2 million, up 61.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.2 million (up 61.22% YoY), and the FY2025 annual result was $2.1 million, up 56.48% from the prior year.
- Other Non-Current Assets came in at $2.2 million for Q4 2025 at Immatics, up from $958625.2 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $5.0 million in Q2 2022 to a low of $710473.1 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $1.4 million (2024), against an average of $1.8 million.
- Across the five-year window, Other Non-Current Assets surged 390.53% in 2022 and plunged 56.98% in 2023, its largest moves.
- Immatics' Other Non-Current Assets stood at $727565.5 in 2021, then soared by 256.88% to $2.6 million in 2022, then slipped by 16.42% to $2.2 million in 2023, then sank by 38.45% to $1.3 million in 2024, then soared by 61.22% to $2.2 million in 2025.
- The last three Other Non-Current Assets figures came in at $2.2 million (Q4 2025), $958625.2 (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 2.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | 958,625.17 |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 2.17 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 4.05 Mn |
| Jun 30, 2022 | 4.99 Mn |
| Mar 31, 2022 | 986,534.85 |
| Dec 31, 2021 | 727,565.52 |
| Sep 30, 2021 | 847,907.58 |
| Jun 30, 2021 | 1.02 Mn |
| Mar 31, 2021 | 710,473.07 |